Peer-Reviewed Journal Details
Mandatory Fields
Kowalski, Piotr S and Kuninty, Praneeth R and Bijlsma, Klaas T and Stuart, Marc and Leus, Niek and Ruiters, Marcel and Molema, Grietje and Kamps, Jan
2015
January
European Journal Of Pharmaceutics And Biopharmaceutics
SAINT-liposome-polycation particles, a new carrier for improved delivery of siRNAs to inflamed endothelial cells
Validated
Optional Fields
89
40
47
Interference with acute and chronic inflammatory processes by means of delivery of siRNAs into microvascular endothelial cells at a site of inflammation demands specific, non-toxic and effective siRNA delivery system. In the current work we describe the design and characterization of siRNA carriers based on cationic pyridinium-derived lipid 1-methyl-4-(cis-9-dioleyl)methyl-pyridinium-chloride) (SAINT-C18) and the transfection enhancer protamine, complexed with siRNA/carrier DNA or siRNA only. These carriers, called SAINT-liposome-polycation-DNA (S-LPD) and SAINT-liposome-polycation (S-LP), have a high efficiency of siRNA encapsulation, low cellular toxicity, and superior efficacy of gene downregulation in endothelial cells in vitro as compared to DOTAP-LPD. Incorporation of 10mol\% PEG and anti-E-selectin antibody in these formulations resulted in selective siRNA delivery into activated endothelial cells. Furthermore, we showed that the physicochemical characteristics of S-LPD and S-LP, including size-stability and maintenance of the siRNA integrity in the presence of serum at 37C, comply with requirements for in vivo application.
10.1016/j.ejpb.2014.11.015
Grant Details